Sandoz Group AG (Sandoz Group AG) Price-to-Operating-Cash-Flow : (As of May. 23, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Sandoz Group AG Price-to-Operating-Cash-Flow?

As of today (2024-05-23), Sandoz Group AG's share price is $35.65. Sandoz Group AG does not have enough years/quarters to calculate the Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023. Therefore GuruFocus does not calculate Price-to-Operating-Cash-Flow Ratio at this moment.

The historical rank and industry rank for Sandoz Group AG's Price-to-Operating-Cash-Flow or its related term are showing as below:

SDZNY' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0 Med: 0 Max: 45.31
Current: 44.59

During the past 2 years, Sandoz Group AG's highest Price-to-Operating-Cash-Flow Ratio was 45.31. The lowest was 0.00. And the median was 0.00.

SDZNY's Price-to-Operating-Cash-Flow is ranked worse than
83.48% of 678 companies
in the Drug Manufacturers industry
Industry Median: 17.245 vs SDZNY: 44.59

Sandoz Group AG's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $0.84.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Sandoz Group AG was -72.50% per year.

Sandoz Group AG Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Sandoz Group AG's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sandoz Group AG Price-to-Operating-Cash-Flow Chart

Sandoz Group AG Annual Data

Trend

Dec22

Dec23

Price-to-Operating-Cash-Flow

38.11

Sandoz Group AG Quarterly Data
	Dec22	Dec23
Price-to-Operating-Cash-Flow	-	-

Competitive Comparison of Sandoz Group AG's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Sandoz Group AG's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sandoz Group AG's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sandoz Group AG's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Sandoz Group AG's Price-to-Operating-Cash-Flow falls into.

Sandoz Group AG Price-to-Operating-Cash-Flow Calculation

Sandoz Group AG's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	35.65	/
	=

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Sandoz Group AG Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Sandoz Group AG's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Sandoz Group AG (Sandoz Group AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sandoz Group AG (OTCPK:SDZNY) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

SDZXF:USA SDZz:UK D8Y0:Germany SDZ:Switzerland

Address

Forum 1, Novartis Campus, Basel, CHE, CH-4056

Website

https://www.sandoz.com

Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $9 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006 as well as U.S.'s first biosimilar, Zarxio, in 2015. It currently has eight commercialized biosimilars in a number of markets and has over 20 assets in pipeline.

Sandoz Group AG (Sandoz Group AG) Headlines

From GuruFocus

Q3 2023 Sandoz Group AG Earnings Call Transcript

By GuruFocus Research • 02-14-2024

Q3 2023 Sandoz Group AG Earnings Call Transcript

By GuruFocus Research • 02-14-2024